|
COPYRIGHT 2003 International Medical News Group
BETHESDA, M. D. -- The Food and Drug Administration has approved memantine, the first drug to treat moderate to severe Alzheimer's disease.
Memantine was approved last year in Europe for moderate to severe Alzheimer's. Its approval in the United States makes memantine the first treatment for advanced stages of the disease. The drug will be marketed by Forest Laboratories Inc. under the trade name Namenda. Dr. Lawrence Olanoff, executive vice president at Forest, said the drug will be available in January...
Read the full article for free courtesy of your local library.
| 
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
